Latent
PrivateLast Round
Series A
Apr 7, 2026
Est. Valuation
$600M
Total Funding Raised
$80.5M
Momentum Score
25 /100
Company Overview
Latent is a technology company that develops medical language models to automate and streamline healthcare operations, reducing administrative costs. Its primary product uses clinical AI to analyze electronic health records (EHR) to accelerate complex medication approval workflows, such as prior authorizations, appeals, and 340B compliance. By extracting and analyzing relevant patient data, the platform aims to help providers, insurers, and pharmaceutical companies simplify specialty medication approvals and enable patients to receive therapies faster. The company was part of Y Combinator's W23 batch.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Workflow Automation, Revenue Cycle, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Latent Comps
Public and private peers based on sector, stage, and business model.
Latent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 7, 2026 | ||||
| Pre Seed | Apr 5, 2023 |
Latent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Conviction Partners | Series A |
| McKesson Ventures | Series A |
| General Catalyst | Series A, Pre Seed |
| Y Combinator | Series A, Pre Seed |
| Spark Capital | Series A |
| Transformation Capital | Series A |
| Conviction Partners Fund II | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Serving over 2 million patients across 45+ health systems.
- Apr 10, 2026
Mayo Clinic disclosed as a new customer.
Latent Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Latent's valuation, stock price, and market status.
